arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

CTT PHARMACEUTICAL HOLDINGS, INC.

CTTH

— Price unavailable

38 Visible periods

17 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

CTT PHARMACEUTICAL HOLDINGS, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC None

FCF / Share None

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

38-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-341.93K

↓ -691.6% —

FCF / Share Free cash flow per share

$-0.00

↑ +64.3% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-Q ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q3 FY2013 Sep 30, 2013 10-Q ↗	Q2 FY2013 Jun 30, 2013 10-Q ↗	Q1 FY2013 Mar 31, 2013 10-Q ↗	Q4 FY2012 Dec 31, 2012 10-K ↗	Q3 FY2012 Sep 30, 2012 10-Q ↗	Q2 FY2012 Jun 30, 2012 10-Q ↗	Q1 FY2012 Mar 31, 2012 10-Q ↗	Q4 FY2011 Dec 31, 2011 10-K ↗	Q3 FY2011 Sep 30, 2011 10-Q ↗	Q2 FY2011 Jun 30, 2011 10-Q ↗	Q1 FY2011 Mar 31, 2011 10-Q ↗	Q4 FY2010 Dec 31, 2010 10-K ↗	Q3 FY2010 Sep 30, 2010 10-Q ↗	Q2 FY2010 Jun 30, 2010 10-Q ↗	Q4 FY2009 Dec 31, 2009 10-K ↗	Q4 FY2008 Dec 31, 2008 10-K ↗	Q4 FY2007 Dec 31, 2007 10-K ↗	Q4 FY2006 Dec 31, 2006 10-K ↗	Q4 FY2005 Dec 31, 2005 10-K ↗	Q4 FY2004 Dec 31, 2004 10-K ↗	Q4 FY2003 Dec 31, 2003 10-K ↗	Q4 FY2002 Dec 31, 2002 10-K ↗	Q4 FY2001 Dec 31, 2001 10-K ↗	Q4 FY2000 Dec 31, 2000 10-K ↗	Q4 FY1999 Dec 31, 1999 10-K ↗	Q4 FY1998 Dec 31, 1998 10-K ↗
EPS Growth YoY (%)	—	—	—	—	—	—	—	—	—	100.0% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	100.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	100.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	—	85.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	60.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	80.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	100.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	16.7% Good Good Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	—	—	—	—	-691.6% Weak ↑ Weak Improving Year-over-year change in net income	-718.7% Weak ↓ Weak Declining Year-over-year change in net income	-1060.8% Weak ↓ Weak Declining Year-over-year change in net income	—	-64.8% Weak ↓ Weak Declining Year-over-year change in net income	30.5% Excellent ↓ Excellent Declining Year-over-year change in net income	28.2% Excellent ↑ Excellent Improving Year-over-year change in net income	—	76.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-79.0% Weak ↓ Weak Declining Year-over-year change in net income	94.1% Excellent ↑ Excellent Improving Year-over-year change in net income	59.0% Excellent ↓ Excellent Declining Year-over-year change in net income	75.3% Excellent ↑ Excellent Improving Year-over-year change in net income	96.7% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	16.4% Good ↑ Good Improving Year-over-year change in net income	0.0% Caution Caution Year-over-year change in net income	-77887.6% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	—	—	—	—	—	—	—	—	64.3% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	76.2% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	—	84.6% Excellent → Excellent Stable Year-over-year change in free cash flow	87.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	88.1% Excellent Excellent Year-over-year change in free cash flow	—	6.7% Fair Fair Year-over-year change in free cash flow	N/M	-4977.7% Weak Weak Year-over-year change in free cash flow	—	85.0% Excellent Excellent Year-over-year change in free cash flow	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-Q ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q3 FY2013 Sep 30, 2013 10-Q ↗	Q2 FY2013 Jun 30, 2013 10-Q ↗	Q1 FY2013 Mar 31, 2013 10-Q ↗	Q4 FY2012 Dec 31, 2012 10-K ↗	Q3 FY2012 Sep 30, 2012 10-Q ↗	Q2 FY2012 Jun 30, 2012 10-Q ↗	Q1 FY2012 Mar 31, 2012 10-Q ↗	Q4 FY2011 Dec 31, 2011 10-K ↗	Q3 FY2011 Sep 30, 2011 10-Q ↗	Q2 FY2011 Jun 30, 2011 10-Q ↗	Q1 FY2011 Mar 31, 2011 10-Q ↗	Q4 FY2010 Dec 31, 2010 10-K ↗	Q3 FY2010 Sep 30, 2010 10-Q ↗	Q2 FY2010 Jun 30, 2010 10-Q ↗	Q4 FY2009 Dec 31, 2009 10-K ↗	Q4 FY2008 Dec 31, 2008 10-K ↗	Q4 FY2007 Dec 31, 2007 10-K ↗	Q4 FY2006 Dec 31, 2006 10-K ↗	Q4 FY2005 Dec 31, 2005 10-K ↗	Q4 FY2004 Dec 31, 2004 10-K ↗	Q4 FY2003 Dec 31, 2003 10-K ↗	Q4 FY2002 Dec 31, 2002 10-K ↗	Q4 FY2001 Dec 31, 2001 10-K ↗	Q4 FY2000 Dec 31, 2000 10-K ↗	Q4 FY1999 Dec 31, 1999 10-K ↗	Q4 FY1998 Dec 31, 1998 10-K ↗
FCF / Net Income (x)	—	—	—	—	0.05x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.08x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.12x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.17x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.93x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.82x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.44x Good ↓ Good Declining Free cash flow relative to reported net income Optimal: > 1x	7.35x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.36x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.43x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.33x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	209.36x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-Q ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q3 FY2013 Sep 30, 2013 10-Q ↗	Q2 FY2013 Jun 30, 2013 10-Q ↗	Q1 FY2013 Mar 31, 2013 10-Q ↗	Q4 FY2012 Dec 31, 2012 10-K ↗	Q3 FY2012 Sep 30, 2012 10-Q ↗	Q2 FY2012 Jun 30, 2012 10-Q ↗	Q1 FY2012 Mar 31, 2012 10-Q ↗	Q4 FY2011 Dec 31, 2011 10-K ↗	Q3 FY2011 Sep 30, 2011 10-Q ↗	Q2 FY2011 Jun 30, 2011 10-Q ↗	Q1 FY2011 Mar 31, 2011 10-Q ↗	Q4 FY2010 Dec 31, 2010 10-K ↗	Q3 FY2010 Sep 30, 2010 10-Q ↗	Q2 FY2010 Jun 30, 2010 10-Q ↗	Q4 FY2009 Dec 31, 2009 10-K ↗	Q4 FY2008 Dec 31, 2008 10-K ↗	Q4 FY2007 Dec 31, 2007 10-K ↗	Q4 FY2006 Dec 31, 2006 10-K ↗	Q4 FY2005 Dec 31, 2005 10-K ↗	Q4 FY2004 Dec 31, 2004 10-K ↗	Q4 FY2003 Dec 31, 2003 10-K ↗	Q4 FY2002 Dec 31, 2002 10-K ↗	Q4 FY2001 Dec 31, 2001 10-K ↗	Q4 FY2000 Dec 31, 2000 10-K ↗	Q4 FY1999 Dec 31, 1999 10-K ↗	Q4 FY1998 Dec 31, 1998 10-K ↗
Return on Invested Capital (%)	—	—	—	—	—	—	-88.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	-20.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	8.2% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	—	4.1% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	10.4% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	11.2% Good Good Return earned on debt + equity capital invested Optimal: > 10%	41.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	-32.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	139.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	—	—	—	—	—	—	-23.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-9.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-158.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-371.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-433.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-153.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-99.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-30.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-51.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-44.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	—	—	—	—	-46.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-409%)	-36.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-345%)	-112.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-847%)	46.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+209%)	—	-51.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-445%)	11.1% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-26%)	—	5.3% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-64%)	13.4% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-11%)	9.5% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-36%)	45.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+204%)	—	—	—	-94.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-728%)	-10.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-24.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-262%)	—	161.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+979%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-Q ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q3 FY2013 Sep 30, 2013 10-Q ↗	Q2 FY2013 Jun 30, 2013 10-Q ↗	Q1 FY2013 Mar 31, 2013 10-Q ↗	Q4 FY2012 Dec 31, 2012 10-K ↗	Q3 FY2012 Sep 30, 2012 10-Q ↗	Q2 FY2012 Jun 30, 2012 10-Q ↗	Q1 FY2012 Mar 31, 2012 10-Q ↗	Q4 FY2011 Dec 31, 2011 10-K ↗	Q3 FY2011 Sep 30, 2011 10-Q ↗	Q2 FY2011 Jun 30, 2011 10-Q ↗	Q1 FY2011 Mar 31, 2011 10-Q ↗	Q4 FY2010 Dec 31, 2010 10-K ↗	Q3 FY2010 Sep 30, 2010 10-Q ↗	Q2 FY2010 Jun 30, 2010 10-Q ↗	Q4 FY2009 Dec 31, 2009 10-K ↗	Q4 FY2008 Dec 31, 2008 10-K ↗	Q4 FY2007 Dec 31, 2007 10-K ↗	Q4 FY2006 Dec 31, 2006 10-K ↗	Q4 FY2005 Dec 31, 2005 10-K ↗	Q4 FY2004 Dec 31, 2004 10-K ↗	Q4 FY2003 Dec 31, 2003 10-K ↗	Q4 FY2002 Dec 31, 2002 10-K ↗	Q4 FY2001 Dec 31, 2001 10-K ↗	Q4 FY2000 Dec 31, 2000 10-K ↗	Q4 FY1999 Dec 31, 1999 10-K ↗	Q4 FY1998 Dec 31, 1998 10-K ↗
Net Debt (USD)	—	—	—	—	$-32.12K	$-46.07K	$-73.45K	$-81.18K	$-125.32K	$-222.11K	$-11.79K	$-823.00	$-1.43K	$-7.92K	$-19.00K	$-12.09K	$-35.74K	$-142.56K	$-181.93K	$-569.38K	—	—	$-396.01K	$-46.19K	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-Q ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q3 FY2013 Sep 30, 2013 10-Q ↗	Q2 FY2013 Jun 30, 2013 10-Q ↗	Q1 FY2013 Mar 31, 2013 10-Q ↗	Q4 FY2012 Dec 31, 2012 10-K ↗	Q3 FY2012 Sep 30, 2012 10-Q ↗	Q2 FY2012 Jun 30, 2012 10-Q ↗	Q1 FY2012 Mar 31, 2012 10-Q ↗	Q4 FY2011 Dec 31, 2011 10-K ↗	Q3 FY2011 Sep 30, 2011 10-Q ↗	Q2 FY2011 Jun 30, 2011 10-Q ↗	Q1 FY2011 Mar 31, 2011 10-Q ↗	Q4 FY2010 Dec 31, 2010 10-K ↗	Q3 FY2010 Sep 30, 2010 10-Q ↗	Q2 FY2010 Jun 30, 2010 10-Q ↗	Q4 FY2009 Dec 31, 2009 10-K ↗	Q4 FY2008 Dec 31, 2008 10-K ↗	Q4 FY2007 Dec 31, 2007 10-K ↗	Q4 FY2006 Dec 31, 2006 10-K ↗	Q4 FY2005 Dec 31, 2005 10-K ↗	Q4 FY2004 Dec 31, 2004 10-K ↗	Q4 FY2003 Dec 31, 2003 10-K ↗	Q4 FY2002 Dec 31, 2002 10-K ↗	Q4 FY2001 Dec 31, 2001 10-K ↗	Q4 FY2000 Dec 31, 2000 10-K ↗	Q4 FY1999 Dec 31, 1999 10-K ↗	Q4 FY1998 Dec 31, 1998 10-K ↗
Basic EPS, GAAP (USD)	—	—	—	—	—	—	—	—	$0.01	$0.00	$0.00	$0.02	$0.00	$-0.01	$-0.01	$-0.02	$-0.01	$0.00	$-0.07	$-0.05	$-0.05	$-0.12	$0.64	$-0.06	$-0.05	$0.00	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	—	—	—	—	—	—	—	—	$-0.00	$-0.00	—	$-0.00	$-0.00	$-0.01	—	$-0.02	$-0.03	$-0.07	—	$-0.02	$0.05	$-0.00	—	$-0.12	$-0.03	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.00	$0.00	—	—	$0.03	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.03	$-0.03	$-0.05	$-0.05	$-0.05	$-0.04	—	—	—	$0.05	$0.45	$0.50	—	$-0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$-0.00	$-0.00	—	—	$0.03	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.03	$-0.03	$-0.05	$-0.05	$-0.05	$-0.04	—	—	—	$0.05	$0.45	$0.50	—	$-0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	—	—	—	—	—	—	—	—	—	22.35M	9.41M	—	9.41M	9.41M	9.41M	—	9.30M	9.30M	9.41M	—	8.90M	8.89M	8.89M	—	8.53M	8.30M	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-Q ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q3 FY2013 Sep 30, 2013 10-Q ↗	Q2 FY2013 Jun 30, 2013 10-Q ↗	Q1 FY2013 Mar 31, 2013 10-Q ↗	Q4 FY2012 Dec 31, 2012 10-K ↗	Q3 FY2012 Sep 30, 2012 10-Q ↗	Q2 FY2012 Jun 30, 2012 10-Q ↗	Q1 FY2012 Mar 31, 2012 10-Q ↗	Q4 FY2011 Dec 31, 2011 10-K ↗	Q3 FY2011 Sep 30, 2011 10-Q ↗	Q2 FY2011 Jun 30, 2011 10-Q ↗	Q1 FY2011 Mar 31, 2011 10-Q ↗	Q4 FY2010 Dec 31, 2010 10-K ↗	Q3 FY2010 Sep 30, 2010 10-Q ↗	Q2 FY2010 Jun 30, 2010 10-Q ↗	Q4 FY2009 Dec 31, 2009 10-K ↗	Q4 FY2008 Dec 31, 2008 10-K ↗	Q4 FY2007 Dec 31, 2007 10-K ↗	Q4 FY2006 Dec 31, 2006 10-K ↗	Q4 FY2005 Dec 31, 2005 10-K ↗	Q4 FY2004 Dec 31, 2004 10-K ↗	Q4 FY2003 Dec 31, 2003 10-K ↗	Q4 FY2002 Dec 31, 2002 10-K ↗	Q4 FY2001 Dec 31, 2001 10-K ↗	Q4 FY2000 Dec 31, 2000 10-K ↗	Q4 FY1999 Dec 31, 1999 10-K ↗	Q4 FY1998 Dec 31, 1998 10-K ↗
Working Capital (USD)	$-41.36K	$-15.66K	—	—	—	—	—	—	—	—	—	$-243.13K	—	—	—	$-386.33K	—	—	—	$-2.98M	$401.43K	$434.34K	—	$-425.05K	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$26.04K	$55.15K	$82.14K	$32.18K	$738.08K	$986.89K	$300.90K	$586.63K	$6.15K	$85.56K	$-262.65K	$-243.13K	$-490.13K	$-476.11K	$-423.95K	$-386.33K	—	—	—	$456.45K	$4.06M	$4.45M	—	$-317.89K	—	—	$-1.25M	$151.39K	$557.86K	$765.03K	$74.21K	$1.92M	$-1.71M	$-577.76K	$-17.61K	$-10.36K	$-83.44K	$-245.66K

📋 What is driving earnings? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-Q ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q3 FY2013 Sep 30, 2013 10-Q ↗	Q2 FY2013 Jun 30, 2013 10-Q ↗	Q1 FY2013 Mar 31, 2013 10-Q ↗	Q4 FY2012 Dec 31, 2012 10-K ↗	Q3 FY2012 Sep 30, 2012 10-Q ↗	Q2 FY2012 Jun 30, 2012 10-Q ↗	Q1 FY2012 Mar 31, 2012 10-Q ↗	Q4 FY2011 Dec 31, 2011 10-K ↗	Q3 FY2011 Sep 30, 2011 10-Q ↗	Q2 FY2011 Jun 30, 2011 10-Q ↗	Q1 FY2011 Mar 31, 2011 10-Q ↗	Q4 FY2010 Dec 31, 2010 10-K ↗	Q3 FY2010 Sep 30, 2010 10-Q ↗	Q2 FY2010 Jun 30, 2010 10-Q ↗	Q4 FY2009 Dec 31, 2009 10-K ↗	Q4 FY2008 Dec 31, 2008 10-K ↗	Q4 FY2007 Dec 31, 2007 10-K ↗	Q4 FY2006 Dec 31, 2006 10-K ↗	Q4 FY2005 Dec 31, 2005 10-K ↗	Q4 FY2004 Dec 31, 2004 10-K ↗	Q4 FY2003 Dec 31, 2003 10-K ↗	Q4 FY2002 Dec 31, 2002 10-K ↗	Q4 FY2001 Dec 31, 2001 10-K ↗	Q4 FY2000 Dec 31, 2000 10-K ↗	Q4 FY1999 Dec 31, 1999 10-K ↗	Q4 FY1998 Dec 31, 1998 10-K ↗
Net Income, GAAP (USD)	—	—	—	—	$-341.93K	$-362.66K	$-337.05K	$271.48K	$-43.20K	$-44.30K	$-29.04K	—	$-26.21K	$-63.71K	$-40.45K	$-176.23K	$-108.99K	$-35.59K	$-682.38K	$-429.86K	$-442.12K	$-1.08M	$5.69M	$-514.35K	$-442.27K	$-1.38K	—	—	—	—	—	—	—	—	—	—	—	—
Operating Cash Flow (USD)	—	—	—	—	$-15.53K	$-29.16K	$-39.65K	$-46.84K	—	$-28.74K	$-17.55K	—	$-24.38K	$-33.87K	$-73.67K	$-89.42K	$-156.58K	$-261.51K	$-619.50K	$200.42K	$-160.73K	$466.33K	$-11.52K	$-239.99K	$-1.03M	$-289.55K	—	—	—	—	—	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 17 years · 38 quarters

CTT PHARMACEUTICAL HOLDINGS, INC.

Analytical Summary

38-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CTTH with peers